How are OMER long put max profit and max loss calculated?

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the OMER long put priced from the end-of-day chain at a 30-day expiry (ATM IV 109.80%), the computed maximum profit is $891.50 per contract and the computed maximum loss is -$107.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a OMER long put?

The breakeven for the OMER long put priced on this page is roughly $8.93 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OMER market-implied 1-standard-deviation expected move is approximately 31.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current OMER implied volatility affect this long put?

OMER ATM IV is at 109.80% with IV rank near 28.93%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

OMER Long Put Strategy

OMER (Omeros Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases. The company's therapeutic endeavors primarily focus on inflammatory conditions, illnesses mediated by the complement system, cancers linked to immune system dysregulation, and disorders characterized by addiction or compulsion. Its robust clinical pipeline features several promising candidates. Narsoplimab (also known as OMS721 or MASP-2), a leading asset, has successfully concluded pivotal trials for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA). This drug is also currently undergoing Phase III clinical evaluation for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS), in addition to a Phase II trial investigating its potential for treating COVID-19. Further expanding its clinical portfolio, Omeros is developing PPAR? (OMS405) in Phase II for opioid and nicotine dependence.

OMER (Omeros Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $627.5M, a trailing P/E of 7.24, a beta of 2.53 versus the broader market, a 52-week range of 2.95-17.65, average daily share volume of 1.6M, a public-listing history dating back to 2009, approximately 202 full-time employees. These structural characteristics shape how OMER stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.53 indicates OMER has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 7.24 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.

What is a long put on OMER?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current OMER snapshot

As of June 30, 2026, spot at $9.63, ATM IV 109.80%, IV rank 28.93%, expected move 31.48%. The long put on OMER below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long put structure on OMER specifically: OMER IV at 109.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a OMER long put, with a market-implied 1-standard-deviation move of approximately 31.48% (roughly $3.03 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OMER expiries trade a higher absolute premium for lower per-day decay. Position sizing on OMER should anchor to the underlying notional of $9.63 per share and to the trader's directional view on OMER stock.

OMER long put setup

The OMER long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OMER near $9.63, the first option leg uses a $10.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OMER chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OMER shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Put	$10.00	$1.08

OMER long put risk and reward

Net Premium / Debit: -$107.50
Max Profit (per contract): $891.50
Max Loss (per contract): -$107.50
Breakeven(s): $8.93
Risk / Reward Ratio: 8.293

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

OMER long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on OMER. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	+$891.50
$2.14	-77.8%	+$678.69
$4.27	-55.7%	+$465.87
$6.39	-33.6%	+$253.06
$8.52	-11.5%	+$40.24
$10.65	+10.6%	-$107.50
$12.78	+32.7%	-$107.50
$14.91	+54.8%	-$107.50
$17.04	+76.9%	-$107.50
$19.16	+99.0%	-$107.50

When traders use long put on OMER

Long puts on OMER hedge an existing long OMER stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying OMER exposure being hedged.

OMER thesis for this long put

The market-implied 1-standard-deviation range for OMER extends from approximately $6.60 on the downside to $12.66 on the upside. A OMER long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long OMER position with one put per 100 shares held. Current OMER IV rank near 28.93% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OMER at 109.80%. As a Healthcare name, OMER options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OMER-specific events.

OMER long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OMER positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OMER alongside the broader basket even when OMER-specific fundamentals are unchanged. Long-premium structures like a long put on OMER are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current OMER chain quotes before placing a trade.

Frequently asked questions

What is a long put on OMER?: A long put on OMER is the long put strategy applied to OMER (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With OMER stock trading near $9.63, the strikes shown on this page are snapped to the nearest listed OMER chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are OMER long put max profit and max loss calculated?: Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the OMER long put priced from the end-of-day chain at a 30-day expiry (ATM IV 109.80%), the computed maximum profit is $891.50 per contract and the computed maximum loss is -$107.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a OMER long put?: The breakeven for the OMER long put priced on this page is roughly $8.93 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OMER market-implied 1-standard-deviation expected move is approximately 31.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on OMER?: Long puts on OMER hedge an existing long OMER stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying OMER exposure being hedged.
How does current OMER implied volatility affect this long put?: OMER ATM IV is at 109.80% with IV rank near 28.93%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.